Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 11-K
(Mark One)
| x | ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the fiscal year ended December 31, 2002
OR
| ¨ | TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission file number 000-12477
AMGEN RETIREMENT AND SAVINGS PLAN
(Full title of the plan)
AMGEN INC.
(Name of issuer of the securities held)
| One Amgen Center Drive, Thousand Oaks, California |
91320-1799 | |
| (Address of principal executive offices) | (Zip Code) |
Table of Contents
Amgen Retirement and Savings Plan
Financial Statements
and Supplemental Schedule
Years ended December 31, 2002 and 2001
Contents
| 1 | ||
| 2 | ||
| 3 | ||
| 4 | ||
| 9 | ||
Table of Contents
Report of Ernst & Young LLP, Independent Auditors
Amgen Inc., as Named Fiduciary, and the Plan Participants
of the Amgen Retirement and Savings Plan
We have audited the accompanying statements of net assets available for benefits of the Amgen Retirement and Savings Plan as of December 31, 2002 and 2001, and the related statements of changes in net assets available for benefits for the years then ended. These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the net assets available for benefits of the Plan at December 31, 2002 and 2001, and the changes in its net assets available for benefits for the years then ended, in conformity with accounting principles generally accepted in the United States.
Our audits were performed for the purpose of forming an opinion on the financial statements taken as a whole. The accompanying supplemental schedule of assets (held at end of year) at December 31, 2002, is presented for purposes of additional analysis and is not a required part of the financial statements but is supplementary information required by the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. This supplemental schedule is the responsibility of the Plan’s management. The supplemental schedule has been subjected to the auditing procedures applied in our audits of the financial statements and, in our opinion, is fairly stated in all material respects in relation to the financial statements taken as a whole.
/s/ ERNST & YOUNG LLP
June 13, 2003
Los Angeles, California
1
Table of Contents
Amgen Retirement and Savings Plan
Statements of Net Assets Available for Benefits
| December 31 | ||||||
| 2002 |
2001 | |||||
| Assets |
||||||
| Investments at fair value |
$ | 640,348,393 | $ | 704,081,616 | ||
| Net assets available for benefits |
$ | 640,348,393 | $ | 704,081,616 | ||
See accompanying notes.
2
Table of Contents
Amgen Retirement and Savings Plan
Statements of Changes in Net Assets Available for Benefits
| Year ended December 31 |
||||||||
| 2002 |
2001 |
|||||||
| Additions to net assets: |
||||||||
| Employee contributions |
$ | 48,818,481 | $ | 45,545,235 | ||||
| Employer contributions |
40,050,692 | 37,865,221 | ||||||
| Interest and dividend income |
7,221,347 | 9,278,622 | ||||||
| Total additions |
96,090,520 | 92,689,078 | ||||||
| Deductions from net assets: |
||||||||
| Benefits paid |
48,214,013 | 28,158,334 | ||||||
| Realized/unrealized losses |
111,609,730 | 87,695,138 | ||||||
| Total deductions |
159,823,743 | 115,853,472 | ||||||
| Net decrease |
(63,733,223 | ) | (23,164,394 | ) | ||||
| Net assets available for benefits at beginning of year |
704,081,616 | 727,246,010 | ||||||
| Net assets available for benefits at end of year |
$ | 640,348,393 | $ | 704,081,616 | ||||
See accompanying notes.
3
Table of Contents
Amgen Retirement and Savings Plan
Notes to Financial Statements
December 31, 2002
1. Description of Plan
The following description of the Amgen Retirement and Savings Plan (the Plan) provides only general information. Participants should refer to the Plan document for a more complete description of the Plan’s provisions.
General
The Plan was established effective April 1, 1985 (amended and restated effective January 1, 1990, January 1, 1993, April 1, 1996, and October 23, 2000, respectively), as a defined contribution plan covering substantially all domestic employees of Amgen Inc. (the Company). The Plan, as amended, is intended to qualify under sections 401(a) and 401(k) of the Internal Revenue Code of 1986 (the Code) and section 407(d)(3)(A) of the Employee Retirement Income Security Act of 1974 (ERISA).
Contributions
During 2002 and 2001, participants could elect to contribute up to 30% and 15%, respectively, of their pretax annual compensation (up to a maximum contribution of $11,000 and $10,500, respectively). Participants may also contribute amounts representing distributions from other qualified defined benefit or defined contribution plans.
Each pay period, the Company makes a contribution of 100% of the first 5% of eligible compensation contributed by the employee (Matching Contribution). In addition, the Company supplements the Matching Contribution for all eligible employees, whether or not they have elected to make contributions to the Plan, with a contribution equal to 3% of each eligible employee’s compensation (Core Contribution).
Participants select the funds in which their contributions are to be invested, electing among various investment alternatives. Participants may elect for their contributions to be invested in more than one fund; however, no more than 50% of their total contributions may be invested in the Amgen Inc. Stock Fund. Participants may change their investment options at any time.
Vesting
Participants are immediately vested with respect to their individual contributions and earnings thereon. Effective January 1, 2002, participants became fully vested with respect to previously unvested Matching Contributions and Core Contributions credited
4
Table of Contents
Amgen Retirement and Savings Plan
Notes to Financial Statements (continued)
1. Description of Plan (continued)
Vesting (continued)
to their respective account through December 31, 2001, and are immediately vested with respect to Matching Contributions and Core Contributions credited to their respective account after January 1, 2002.
During 2001, participants vested in the Company contributions upon completing a requisite number of years of service. Employees had to work a minimum of 1,000 hours within a plan year to receive vesting for that year of service. For the Matching Contribution, participants vested in their allocated Matching Contribution and related earnings on a pro rata basis after four years of service. For the Core Contribution, participants would become vested in their allocated Core Contribution and related earnings after five years of service, with no partial vesting during the five years. Company contributions became fully vested upon attainment of normal retirement age, disability or death.
Participant Accounts
Each participant’s account is credited with the participant’s contributions and an allocation of (a) Company contributions and (b) Plan earnings and losses. The benefit to which a participant is entitled is the benefit that can be provided from the participant’s account. Forfeited balances of terminated participants’ nonvested accounts during 2001 were used to reduce future Company contributions. Effective January 1, 2002, participants are immediately vested with respect to Matching Contributions and Core Contributions.
Payments of Benefits
Upon termination of service due to death, disability (as defined by the Plan) or retirement, a participant may elect to receive an amount equal to the value of the participant’s vested account balance in either a lump-sum payment in cash and/or full shares of the Company’s common stock. The number of shares of Company common stock to be paid is based on the quoted market value of such stock on the date the Plan is valued following employee notification. Participants hired before April 1, 1996 may also elect to have an insurance annuity contract purchased on the participant’s behalf.
Certain restrictions apply to withdrawals of amounts from the Plan while a participant continues to be employed by the Company.
5
Table of Contents
Amgen Retirement and Savings Plan
Notes to Financial Statements (continued)
1. Description of Plan (continued)
Participant Loans
Subject to Company approval, participants can generally obtain a loan from their account up to the lesser of an amount equal to 50% of the participant’s vested account balance or $50,000, less any outstanding loans. The loans bear interest at average borrowing rates of certain major banks (ranging from 6.50% to 11.87%) and are generally payable in installments over periods ranging from one to five years, unless the loan is used to acquire a principal residence. Principal and interest payments are allocated to the participant’s account.
Plan Termination
Although it has not expressed any intent to do so, the Company has the right under the Plan to terminate the Plan subject to the provisions of ERISA.
Trustee
Fidelity Management Trust Company acts as the Plan’s trustee.
2. Summary of Significant Accounting Policies
Basis of Accounting
The financial statements have been prepared on the accrual basis of accounting.
Investment Income and Losses
Dividend income is recognized on the ex-dividend date and interest income is recorded on an accrual basis. Unrealized gains and losses on investments are measured by the change in the difference between the fair value and cost of the securities held at the beginning and end of the period. Realized gains and losses from security transactions are recorded based on the weighted-average cost of securities sold.
Investment Valuation
Investments in mutual funds and Amgen Inc. common stock are valued at current market values determined through reference to public market information on the last business
6
Table of Contents
Amgen Retirement and Savings Plan
Notes to Financial Statements (continued)
2. Summary of Significant Accounting Policies (continued)
Investment Valuation (continued)
day of the Plan year. Participant loans are valued at their outstanding balances which approximate fair value.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
3. Investments
The fair value of individual investments that represent 5% or more of the Plan’s net assets are as follows:
| December 31 | ||||||
| 2002 |
2001 | |||||
| Amgen Inc. Common Stock |
$ | 186,234,961 | $ | 228,503,831 | ||
| Fidelity Magellan Fund |
80,102,271 | 102,100,754 | ||||
| Fidelity Growth and Income Portfolio |
61,051,319 | 73,223,177 | ||||
| Fidelity Retirement Money Market Portfolio |
56,683,681 | 46,752,550 | ||||
| Fidelity Spartan U.S. Equity Index |
39,019,464 | 48,267,602 | ||||
| Fidelity OTC Portfolio |
35,723,215 | 45,378,930 | ||||
| Fidelity Contrafund |
33,571,163 | 32,519,132 | ||||
During 2002 and 2001, the Plan’s investments (including gains and losses on investments bought and sold, as well as held during the year) depreciated in value as follows:
| Year ended December 31 |
||||||||
| 2002 |
2001 |
|||||||
| Amgen Inc. Common Stock |
$ | (31,237,615 | ) | $ | (29,793,683 | ) | ||
| Mutual funds |
(80,372,115 | ) | (57,901,455 | ) | ||||
| $ | (111,609,730 | ) | $ | (87,695,138 | ) | |||
7
Table of Contents
Amgen Retirement and Savings Plan
Notes to Financial Statements (continued)
4. Income Tax Status
The Plan has received a determination letter from the Internal Revenue Service dated November 21, 2001, stating that the Plan is qualified, in form, under Section 401(a) of the Internal Revenue Code (the Code) and, therefore, the related trust is exempt from taxation. Once qualified, the Plan is required to operate in conformity with the Code to maintain its qualification. The Company believes the Plan is being operated in compliance with the applicable requirements of the Code and, therefore, believes that the Plan is qualified and the related trust is tax exempt. Subsequent amendments have been structured to, and are intended to, maintain the Plan’s tax qualified status.
5. Services Provided by the Company
The Company provides certain administrative and recordkeeping services for the Plan at no cost to the Plan participants. In addition, the Company has paid the trustee fees and other related costs on behalf of the Plan.
6. Assets Transferred from Immunex Corporation
Effective January 1, 2003, the Company merged the Amgen Inc. Profit Sharing 401(k) Plan and Trust (formerly the Immunex Corporation Profit Sharing 401(k) Plan and Trust) (the Immunex Plan) into the Plan. The merged Plan conforms to the terms of the Plan. Employees eligible to participate in the Immunex Plan during 2002 were eligible to participate in the Plan effective January 1, 2003. On January 17, 2003 and January 21, 2003, assets totaling $91,512,183 held by the merged Immunex Plan were transferred to the Plan.
8
Table of Contents
Amgen Retirement and Savings Plan
EIN: 95-3540776
Plan: 35274
Schedule H, line 4i – Schedule of Assets (Held at End of Year)
December 31, 2002
| Identity of Issue |
Description of Investment |
Current Value | |||
| Amgen Inc.* |
Common stock 3,852,358 shares | $ | 186,234,961 | ||
| Fidelity Magellan Fund* |
Mutual fund 1,014,466 shares | 80,102,271 | |||
| Fidelity Growth and Income Portfolio* |
Mutual fund 2,014,230 shares | 61,051,319 | |||
| Fidelity Retirement Money Market Portfolio* |
Money market portfolio | 56,683,681 | |||
| Fidelity Spartan U.S. Equity Index* |
Mutual fund 1,252,631 shares | 39,019,464 | |||
| Fidelity OTC Portfolio* |
Mutual fund 1,494,070 shares | 35,723,215 | |||
| Fidelity Contrafund* |
Mutual fund 869,719 shares | 33,571,163 | |||
| Fidelity Overseas Fund* |
Mutual fund 1,094,154 shares | 24,071,387 | |||
| Fidelity U.S. Bond Index Portfolio* |
Mutual fund 2,039,601 shares | 22,925,110 | |||
| Fidelity Asset Manager: Growth* |
Mutual fund 1,746,016 shares | 20,899,811 | |||
| Fidelity Short-Term Bond* |
Mutual fund 2,023,952 shares | 18,195,328 | |||
| Neuberger Berman Genesis Trust |
Mutual fund 643,079 shares | 18,096,234 | |||
| Fidelity Asset Manager* |
Mutual fund 1,171,979 shares | 16,173,314 | |||
| Fidelity Asset Manager: Income* |
Mutual fund 504,157 shares | 5,475,145 | |||
| Fidelity Equity Income Fund* |
Mutual fund 117,244 shares | 4,651,082 | |||
| Dreyfus Founders Discovery Fund |
Mutual fund 149,767 shares | 2,851,571 | |||
| Invesco Growth Fund |
Mutual fund 777,671 shares | 1,189,836 | |||
| Participant loans* |
Interest rates from 6.50% to 11.87% | 13,433,501 | |||
| $ | 640,348,393 | ||||
* Party-in-interest.
9
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.
| Amgen Retirement and Savings Plan (Name of Plan) | ||||||||
| Date: | 6/30/03 |
By: | /s/ RICHARD D. NANULA | |||||
| Richard D. Nanula Executive Vice President, Finance, Strategy and Communications, and Chief Financial Officer Amgen Inc. | ||||||||
10
Table of Contents
AMGEN RETIREMENT AND SAVINGS PLAN
INDEX TO EXHIBIT
Consent of Ernst & Young LLP, Independent Auditors Exhibit 23
EXHIBIT 23
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 33-39104) pertaining to the Amgen Retirement and Savings Plan of our report dated June 13, 2003, with respect to the financial statements and supplemental schedule of the Amgen Retirement and Savings Plan included in this Annual Report (Form 11-K) for the year ended December 31, 2002.
/s/ ERNST & YOUNG LLP
Los Angeles, California
June 25, 2003